ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,980.87
      -0.03%
      US Tech 100
      21,158.40
      -0.02%
      Dow Jones
      42,171.66
      -0.10%
      Brent Oil
      76.39
      1.74%
      Bitcoin
      104,724.71
      -0.18%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Aptose Biosciences Inc (APTO) Quote

      Aptose Biosciences Inc

      Aptose Biosciences Inc (APTO)

      NASDAQ
      1.71
      0.00
      (0.00%)
      Closed June 19 4:00PM
      15 min delayed - Upgrade to Realtime
      0.00
      0.00
      (0.00%)
      After Hours: -
      15 min delayed - Upgrade to Realtime

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.71
      Bid
      1.51
      Ask
      1.73
      Volume
      -
      0.00 Day's Range 0.00
      1.35 52 Week Range 26.997
      Market Cap
      4.365M
      Previous Close
      1.71
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      12,364
      Shares Outstanding
      2,552,429
      Dividend Yield
      -
      PE Ratio
      -0.45
      Earnings Per Share (EPS)
      -9.96
      Revenue
      -
      Net Profit
      -25.43M

      About Aptose Biosciences Inc

      Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux... Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.aptose.com
      Headquarters
      Mississauga, Ontario, Can
      Founded
      -
      Aptose Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APTO. The last closing price for Aptose Biosciences was $1.71. Over the last year, Aptose Biosciences shares have traded in a share price range of $ 1.35 to $ 26.997.

      Aptose Biosciences currently has 2,552,429 shares outstanding. The market capitalization of Aptose Biosciences is $4.36 million. Aptose Biosciences has a price to earnings ratio (PE ratio) of -0.45.

      Ask ADVFN Intelligence (AI)

      APTO Latest News

      More News

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 08 2025
      APTO (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 08 2025
      APTO (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 05 2025
      APTO (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      April 23 2025
      APTO (0.00%)

      Form PRER14A - Preliminary Proxy Soliciting materials
      Edgar (US Regulatory)
      April 23 2025
      APTO (0.00%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1001.711.711.7100CS
      4001.711.711.7100CS
      12-1.85-51.96629213483.563.761.35123641.90507738CS
      26-3.84-69.18918918925.5511.6851.3559176256.99614135CS
      52-24.69-93.522727272726.426.9971.3532274887.1949108CS
      156-380.79-99.5529411765382.54141.35118237228.43967466CS
      260-3058.29-99.9441176471306032851.351261451893.04888638CS

      APTO - Frequently Asked Questions (FAQ)

      What is the current Aptose Biosciences share price?
      The current share price of Aptose Biosciences is $ 1.71
      How many Aptose Biosciences shares are in issue?
      Aptose Biosciences has 2,552,429 shares in issue
      What is the market cap of Aptose Biosciences?
      The market capitalisation of Aptose Biosciences is USD 4.36M
      What is the 1 year trading range for Aptose Biosciences share price?
      Aptose Biosciences has traded in the range of $ 1.35 to $ 26.997 during the past year
      What is the PE ratio of Aptose Biosciences?
      The price to earnings ratio of Aptose Biosciences is -0.45
      What is the reporting currency for Aptose Biosciences?
      Aptose Biosciences reports financial results in USD
      What is the latest annual profit for Aptose Biosciences?
      The latest annual profit of Aptose Biosciences is USD -25.43M
      What is the registered address of Aptose Biosciences?
      The registered address for Aptose Biosciences is 5955 AIRPORT ROAD, MISSISSAUGA, ONTARIO, L4V 1R9
      What is the Aptose Biosciences website address?
      The website address for Aptose Biosciences is www.aptose.com
      Which industry sector does Aptose Biosciences operate in?
      Aptose Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NWGLNature Wood Group Ltd
      $ 5.615
      (142.03%)
      		5.98M
      KWEKWESST Micro Systems Inc
      $ 11.2296
      (94.96%)
      		37.36M
      PTLEPTL Ltd
      $ 0.3656
      (84.74%)
      		404.15M
      APVOAptevo Therapeutics Inc
      $ 5.01
      (77.66%)
      		124.46M
      MRINMarin Software Incorporated
      $ 1.435
      (68.82%)
      		50.06M
      CBIOCrescent Biopharma Inc
      $ 14.60
      (-71.45%)
      		97.59k
      CEROCERo Therapeutics Holdings Inc
      $ 11.5501
      (-41.75%)
      		3.03M
      BMEABiomea Fusion Inc
      $ 1.90
      (-34.48%)
      		11.66M
      PSTVPlus Therapeutics Inc
      $ 0.2025
      (-34.38%)
      		23.9M
      CONIGraniteShares ETF Trust 2X Short COIN Daily ETF
      $ 3.7198
      (-32.49%)
      		21.46M
      HCTIHealthcare Triangle Inc
      $ 0.0265
      (19.91%)
      		455.2M
      PTLEPTL Ltd
      $ 0.3656
      (84.74%)
      		404.15M
      GNLNGreenlane Holdings Inc
      $ 0.01035
      (-0.48%)
      		260.94M
      NVDANVIDIA Corporation
      $ 145.48
      (0.94%)
      		161.49M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 12.365
      (3.56%)
      		141.16M

      APTO Discussion

      View Posts
      Zeppo Zeppo 3 weeks ago
      Well....I have had six entries in the past 3 1/2 months. I guess I'm about through here. My 3-5-25 entry was somewhat tongue-in-cheek.......but then the company announces yet ANOTHER reverse split at the abbreviated annual meeting. No date or amount given....but it could be from a 1 for 2 to a 1 for 20. The company's accountants bailed. One might wonder why. Anywhoooo.......it's time to move on. I'll keep an eye on it from time to time, but I am not going to bother you all with my concerns over this outfit.
      šŸ‘ļø0
      Zeppo Zeppo 4 weeks ago
      $1.68 The short/intermediate term issue is that there doesn't seem to be any catalyst to drive this stock forward until the "partners" actually settle on a dosage, expand the Phase 1/2 trial to cover enough people to make it meaningful, and somehow decide that enough is enough and apply for Phase III. Does anyone want to guess on a timeframe?
      šŸ‘ļø0
      Zeppo Zeppo 2 months ago
      An April 17 close of $1.97 and this morning at $2.20.
      šŸ‘ļø0
      Renee Renee 3 months ago
      APTO changed to APTOF. Delisted from the Nasdaq to the OTCL

      https://otce.finra.org/otce/dailyList?viewType=Additions
      šŸ‘ļø0
      Zeppo Zeppo 3 months ago
      Wow.......$2.67. This thing might be ready for a "buy" after the next reverse split. There won't be much stock left.
      šŸ‘ļø0
      Zeppo Zeppo 4 months ago
      So....in three days post split the stock has dropped from $3.64 to $3.09.
      šŸ‘ļø0
      TrendTrade2016 TrendTrade2016 4 months ago
      APTO POST SPLIT POPPA
      šŸ‘ļø0
      getmoreshares getmoreshares 4 months ago
      1 for 30 R/S on Feb 26th
      šŸ‘ļø0
      green maschine green maschine 4 months ago
      R/S on Feb 26th
      šŸ‘ļø0
      Zeppo Zeppo 4 months ago
      Today's press release refers to Round 3 of dosage experiments.......this time with the combo.
      šŸ‘ļø0
      Triple nickle Triple nickle 4 months ago
      For the time being it's holding on .32 ??????
      šŸ‘ļø0
      glenn1919 glenn1919 4 months ago
      APTO.....................................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
      šŸ‘ļø0
      GalacticDruid45 GalacticDruid45 4 months ago
      REVERSE SPLIT APPROVED ( JANUARY 27, 2025 )... REVERSE SPLIT DATE ANNOUNCEMENT IMMINENT
      👍️ 1
      Zeppo Zeppo 4 months ago
      You'll notice that recent announcements have NOT propelled the stock upward. Reverse splits are not dilutive, but new stock offerings, to the public or as a private placement, are dilutive because they do affect the percentage of ownership for each shareholder. The product results news has been positive so far, but it will take administering the product to many more patients just to get out of Phase 1/2 and into Phase 3. I assume these stock offerings will be made post-split.
      šŸ‘ļø0
      Invest-in-America Invest-in-America 4 months ago
      APTO: I have to take a SONG break!! (My new Los Angeles County, California, THEME SONG!! Which should be REQUIRED LISTENING for all the STUPID County Officials who reside therein. As auditory PUNISHMENT, of sorts, for NEVER doing what has had to be accomplished there for 70+-YEARS!!! Namely, systematically REMOVING FOREVER every single TREE, BUSH, SHRUB, & BLADE OF GRASS therein!!! For at least 1.5-MILES around all housing developments throughout that stupid County!!! And then COVER that entire area permanently with GRAVEL, STONE, CONCRETE, STAINLESS STEEL, etc., FOREVER!!!)

      šŸ‘ļø0
      Invest-in-America Invest-in-America 4 months ago
      APTO: Looks like this has a Wall Street Police ROADBLOCK at $0.25 cents!!! (DAMN-IT!!!)
      šŸ‘ļø0
      Invest-in-America Invest-in-America 4 months ago
      APTO: And I hope ya take us BOTH to $2.00, by the end of this SLOOOOOOOOW day, Bro!!!!
      šŸ‘ļø0
      LowFloatLopes LowFloatLopes 4 months ago
      In at .24 
      šŸ‘ļø0
      Invest-in-America Invest-in-America 4 months ago
      APTO: Holy STOCK EXPLOSION, Batman!!! What-the-FLUCK was that???!!! (Fret not, Robin!!! Just continue our glorious laughin'-&-runnin' all the way to our BANK!!!)

      šŸ‘ļø0
      Invest-in-America Invest-in-America 4 months ago
      APTO: I grabbed some. (But, any "DD" behind this firm is [supposedly] not very encouraging; hope I'm WRONG!!)
      šŸ‘ļø0
      PinkPennies PinkPennies 4 months ago
      APTO very nice news

      Three patients with unmutated (wildtype) FLT3 (FLT3-WT) completed Cycle 1 of treatment with no dose-limiting toxicities (DLTs) and no dose adjustments.

      Two FLT3-WT patients achieved complete remissions (CR and CRh) by the end of Cycle 1.

      Notably, a patient with biallelic TP53 mutations and a complex karyotype obtained CR.

      The third FLT3-WT patient experienced significant reductions in bone marrow leukemic blasts during Cycle 1 and remains on therapy in Cycle 2.
      šŸ‘ļø0
      Dantheoneman Dantheoneman 4 months ago
      Ticker: NXU. 600 Billion Market Merge just Approved! Moon 
      šŸ‘ļø0
      TrendTrade2016 TrendTrade2016 4 months ago
      I SEE A RS HAS BEEN VOTED IN 1-10 TO 1-30
      šŸ‘ļø0
      TrendTrade2016 TrendTrade2016 4 months ago
      APTO 6 WEEKS TO DELIST...SO RS NEWS SHOULD COME SOON...
      šŸ‘ļø0
      Invest-in-America Invest-in-America 4 months ago
      APTO: Nice news!!!
      https://finance.yahoo.com/news/aptose-frontline-triple-drug-therapy-120000446.html
      šŸ‘ļø0
      glenn1919 glenn1919 4 months ago
      APTO.........................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
      šŸ‘ļø0
      Zeppo Zeppo 5 months ago
      Well......have you all seen the latest correspondence from the company? Yup........another reverse split is on the way. I was ornery and voted against it.
      šŸ‘ļø0
      glenn1919 glenn1919 6 months ago
      APTO..........https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
      šŸ‘ļø0
      Scotty9 Scotty9 6 months ago
      Looks like a Iā€™m going to take a loss on this one
      šŸ‘ļø0
      Zeppo Zeppo 6 months ago
      Okay, everyone. The company basically has three months to get its act together and retain its NASDAQ listing. No revenues are projected for 2025. These new collaborations are going to take time to develop. The last time the company had to scramble to retain its NASDAQ listing, what did it have to do? A reverse split. The company hasn't even been able to find its own way to Phase !!! testing with Tus....let alone Lux. So....what is it going to have to do again....unless its gets some blockbuster FDA news by March 31? Another reverse split. This day has been coming since the last reverse split was done.
      šŸ‘ļø0
      glenn1919 glenn1919 6 months ago
      apto............................https://stockcharts.com/h-sc/ui?s=apto&p=W&b=5&g=0&id=p86431144783
      šŸ‘ļø0
      knrorrel knrorrel 6 months ago
      https://ih.advfn.com/stock-market/NASDAQ/aptose-biosciences-APTO/stock-news/95133778/aptose-announces-positive-decision-by-nasdaq-heari
      šŸ‘ļø0
      knrorrel knrorrel 6 months ago
      lol


      sorry
      šŸ‘ļø0
      knrorrel knrorrel 6 months ago
      lol - nice Post
      šŸ‘ļø0
      tw0122 tw0122 6 months ago
      Nice making another round 
      šŸ‘ļø0
      Invest-in-America Invest-in-America 6 months ago
      "EOIC", like at this link???
      https://www.google.com/search?q=What+does+%22EOIC%22+mean+in+street+slang%3F&sca_esv=790e11adc1912a92&source=hp&ei=YJ1kZ8HrO-PbkPIPxKCYyAY&iflsig=AL9hbdgAAAAAZ2SrcT_uYmDaX2twpgyJ6L581HqdxC_A&ved=0ahUKEwjBm6ST8LSKAxXjLUQIHUQQBmkQ4dUDCBU&oq=What+does+%22EOIC%22+mean+in+street+slang%3F&gs_lp=Egdnd3Mtd2l6IiZXaGF0IGRvZXMgIkVPSUMiIG1lYW4gaW4gc3RyZWV0IHNsYW5nPzIHECEYoAEYCjIHECEYoAEYCjIHECEYoAEYCjIHECEYoAEYCkjywwJQAFi7dnAEeACQAQCYAeUBoAG1HKoBBzE2LjEzLjO4AQzIAQD4AQGYAiSgAssgwgIKEAAYgAQYRhj5AcICCBAAGIAEGLEDwgIFEAAYgATCAg4QABiABBixAxiDARiKBcICBxAAGIAEGArCAgwQABiABBgKGEYY-QHCAgcQABiABBgNwgIGEAAYFhgewgIIEAAYCBgNGB7CAgsQABiABBiGAxiKBcICCBAAGIAEGKIEwgIFECEYqwKYAwCSBwcxMy4yMC4zoAeN-wE&sclient=gws-wiz
      ////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
      Or, did you mean to type, "EPIC"????
      šŸ‘ļø0
      Invest-in-America Invest-in-America 6 months ago
      APTO: No brainer here, K-N-R, in my STUPID opinion!!! (Heck, I just scalped a cheap Lotto Ticket [$1K] on @NVDI in the Post-M several minutes ago for $300 profit; 'small potatoes' for sure, but given this latest rage of JUST-RESCUED-FOR-CONTINUED-NASDAQ-LISTING late PR's, who can resist this stuff???!!!)
      👍️ 1
      knrorrel knrorrel 6 months ago
      Sounds eoic
      šŸ‘ļø0
      knrorrel knrorrel 6 months ago
      holy ahi_ ....coming Dollarland tomorrow ??
      šŸ‘ļø0
      Invest-in-America Invest-in-America 6 months ago
      APTO: Flip-&-scalp these NASDAQ orphans all day long!!!
      šŸ‘ļø0
      Invest-in-America Invest-in-America 6 months ago
      APTO: Back on the NASDAQ, a little more securely!!! (Another 10-bagger???)
      šŸ‘ļø0
      TheFinalCD TheFinalCD 6 months ago
      $APTO Aptose Announces Positive Decision by Nasdaq Hearings Panel

      Pop on this— AlertsAndNews (@AlertsAndNews) December 19, 2024
      šŸ‘ļø0
      Zeppo Zeppo 7 months ago
      Well....a Phase III push for Tus is on the back burner again. First the company decides to go it alone but can't decide on a dosage. Then it wants to partner with a 2nd party.......and now a 3rd. Comments, anyone?
      šŸ‘ļø0
      tw0122 tw0122 9 months ago
      In some .38s looks bottomy typical hedgie beat down bio
      šŸ‘ļø0
      Monksdream Monksdream 9 months ago
      APTO new 52=week low
      šŸ‘ļø0
      Monksdream Monksdream 9 months ago
      APTO new 52 week low
      šŸ‘ļø0
      Zeppo Zeppo 9 months ago
      Another reverse split seems inevitable. The cash infusion, hopefully, will hasten the company to eventually reach a Phase III status on Tusp sometime during my lifetime.
      šŸ‘ļø0
      Laster Laster 9 months ago
      Bought some AH Friday. What a huge mistake.
      Looks like today it will retrace back to $0.50 or lower.
      Oh well.
      šŸ‘ļø0
      glenn1919 glenn1919 10 months ago
      APTO.....................................https://stockcharts.com/h-sc/ui?s=APTO&p=W&b=5&g=0&id=p86431144783
      šŸ‘ļø0
      Imokhopeur Imokhopeur 10 months ago
      Buy
      šŸ‘ļø0

      Your Recent History

      NASDAQ
      APTO
      Aptose Biosciences
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads